PK Study on Ready-to-Use Injection (VSLI-RTU) 1 Vial & 3 Vial Formulation Marqibo® in Hematological Malignant Patients
Clinical trial NCT04243434 · UNKNOWN
Trial details
- NCT number
- NCT04243434
- Sponsor
- Acrotech Biopharma Inc.
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-08-15
- Primary completion
- 2020-08-15
- Enrollment
- 56
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.